HEPA Hepion Pharmaceuticals, Inc.: institutional ownership and insider trading
1 funds reported holding $0 of Hepion Pharmaceuticals, Inc. in their latest 13F filings; in Q2 2026 funds net bought $0, with 0 new positions and 0 funds selling out; over the last 12 months insiders bought $1.24M and sold $0 on the open market.
Largest institutional holders of HEPA
- Ancora Advisors LLC — $0
Recent HEPA insider trades
- Sep 29, 2026: Fisher Danina bought 200,000 shares ($10.0K)
- Aug 3, 2026: LoPriore Vincent S bought 10,000,000 shares ($500K)
- Aug 3, 2026: Appajosyula Sireesh bought 2,000,000 shares ($100K)
- Aug 3, 2026: Purcell Michael J. bought 2,000,000 shares ($100K)
5%+ owners
- Vincent LoPriore: 26.2% (Schedule 13D/A, filed Aug 20, 2026)
- Black Global 5 LLC: 11.1% (Schedule 13D, filed Aug 7, 2026)
- KI Holdings Ltd.: 10.2% (Schedule 13D/A, filed Sep 16, 2026)
- BIGGER CAPITAL FUND L P: 10.0% (Schedule 13G, filed Jan 24, 2025)
- Kenneth Rickel: 7.2% (Schedule 13G/A, filed Oct 21, 2026)
- Gary Stetz: 5.7% (Schedule 13D, filed Aug 20, 2026)